The UPs and DOWNs of MITF in melanoma resistance
- PMID: 25476804
- DOI: 10.1111/pcmr.12338
The UPs and DOWNs of MITF in melanoma resistance
Comment on
-
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.Cancer Discov. 2014 Jul;4(7):816-27. doi: 10.1158/2159-8290.CD-13-0424. Epub 2014 Apr 25. Cancer Discov. 2014. PMID: 24771846 Free PMC article.
-
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.Nat Commun. 2014 Dec 15;5:5712. doi: 10.1038/ncomms6712. Nat Commun. 2014. PMID: 25502142 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical